Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (2): 278-282. doi: 10.19723/j.issn.1671-167X.2022.02.013

Previous Articles     Next Articles

Validation of the Pollard’s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia

GAO Chao,CHEN Li-hong(),WANG Li,YAO Hong,HUANG Xiao-wei,JIA Yu-bo,LIU Tian()   

  1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2020-07-31 Online:2022-04-18 Published:2022-04-13
  • Contact: Li-hong CHEN,Tian LIU E-mail:13901007280@163.com;mikle317@163.com

RICH HTML

  

Abstract:

Objective: To evaluate the sensitivity and specificity of Pollard’s classification criteria(2010) for the diagnosis of rheumatoid arthritis (RA) patients withfibromyalgia (FM) in Chinese patients, and to assess the clinical features and psychological status of RA-FM patients in a real-world observational setting. Methods: Two hundred and two patients with rheumatoid arthritis were enrolled from the outpatients in Rheumatology and Immunology Department in Peking University People’s Hospital. All the patients were evaluated whether incorporating fibromyalgia translation occured using the 1990 American College of Rheumatolgy (ACR)-FM classification criteria. Forty two RA patients were concomitant with FM, while the other one hundred and sixty RA patients without FM were set as the control group. Results: There was no significant difference in general demography between the two groups (P>0.05). In this study, the Pollard’s classification criteria (2010) for RA-FM in Chinese patients had a high sensitivity of 95.2% and relatively low specificity of 52.6%. Compared with those patients without FM, RA patients with FM (RA-FM patients) had higher Disease Activity Scale in 28 joints (DAS-28) score (5.95 vs. 4.38, P=0.011) and much more 28-tender joint counts (TJC) (16.5 vs.4.5, P<0.001).RA-FM patients had worse Health Assessment Questionnaire (HAQ) score (1.24 vs. 0.66, P<0.001) and lower SF-36 (28.63 vs. 58.22, P<0.001). Fatigue was more common in RA-FM patients (88.1% vs. 50.6%,P<0.001) and the degree of fatigue was significantly increased in RA-FM patients (fatigue VAS 5.55 vs. 3.55, P<0.001). RA-FM patients also had higher anxiety (10 vs.4, P<0.001) and depression scores (12 vs.6, P<0.001). erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), morning stiffness time and 28-swollen joint counts (SJC) showed no difference between these two groups. Conclusion: The Pollard’s classification criteria (2010) for RA-FM are feasible in Chinese rheumatoid arthritis patients. The Pollard’s classification criteria is highly sensitive in clinical application, while the relativelylow specificity indicates that various factors need to be considered in combination. RA patients with FM result in higher disease activity,worse function aland psychological status. RA patients with FM also have poorer quality of life. DAS-28 scores may be overestimated in RA patients with FM. In a RA patient thatdoes not reach remission, the possibility of fibromyalgia should be con-sidered.

Key words: Rheumatoid arthritis, Fibromyalgia, Classification

CLC Number: 

  • R593.22

Table 1

Demographic characteristics of RA patients with FM vs. those without FM"

Feature RA (n=160) RA-FM (n=42) P
Age/years, M(P25,P75) 64 (56, 71) 62.5 (56, 71.5) 0.779
Disease duration/years, M(P25,P75) 9 (4, 17.8) 11.5 (2, 21) 0.617
Gender, n(%) 0.567
Male 33 (20.6) 7 (16.7)
Female 127 (79.4) 35 (83.3)
Smoking, n(%) 144/160 (90.0) 37/42 (88.1) 0.939
Education, n(%) 0.584
Primary 26 (16.3) 9 (21.4)
Junior 47 (29.4) 11 (26.2)
Senior 41 (25.6) 14 (33.3)
Higher education 46 (28.8) 8 (19.0)
Race, n(%) 0.755
Han 152 (95.0) 41 (97.6)
Others 8 (5.0) 1 (2.4)
Marital status, n(%) 0.536
Married 155 (96.9) 42 (100.0)
Unmarried 5 (3.1) 0 (0)
Occupation, n(%) 0.792
Employed 16 (10.0) 2 (4.8)
Retired 113 (70.6) 30 (71.4)
Other 31 (19.4) 10 (23.8)

Table 2

Clinical and immunological characteristics of RA patients with FM vs. those without FM"

Feature RA (n=160) RA-FM (n=42) P
DAS28, x -±s 4.38±1.37 5.95±1.21 0.011
TJC, M(P25, P25) 4.5 (1, 8) 16.5 (10, 24) <0.001
SJC, M(P25, P25) 1 (0, 3.75) 2 (0.75, 4) 0.470
Morning stiffness/min, M(P25, P25) 15 (0, 60) 25 (3.75, 99) 0.062
CRP/(mg/dL), M(P25, P25) 14.89 (4.10, 36.14) 27.86 (2.95, 54.68) 0.152
ESR/(mm/h), M(P25, P25) 43.50 (17.00, 70.75) 50.50 (16.75, 76.50) 0.518

Table 3

Quality of life and functional status of RA patients with FM vs. those without FM"

Feature RA (n=160) RA-FM (n=42) P
HAQ, M(P25, P25) 0.66 (0.20, 0.90) 1.24 (0.26, 1.50) <0.001
VAS/cm, M(P25, P25) 3 (2, 5) 5 (3, 7) 0.01
SF36, M(P25, P25) 58.22 (47.26, 73.17) 28.63 (19.80, 39.97) <0.001

Table 4

Psychological and fatigue characteristics of RA patients with FM vs. those without FM"

Feature RA (n=160) RA-FM (n=42) P-value
Anxiety 4 (1, 7) 10 (8, 12) <0.001
Depressed 6 (3, 8) 12 (10, 15) <0.001
Fatigue 81/160 37/42 <0.001
Fatigue VAS 3.55 (1.00, 4.73) 5.55 (4.61, 5.91) <0.001
[1] Clauw DJ. Fibromyalgia: A clinical review[J]. JAMA, 2014, 311(15):1547-1555.
doi: 10.1001/jama.2014.3266
[2] Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population[J]. Arthritis Rheum, 1995, 38(1):19-28.
doi: 10.1002/art.v38:1
[3] Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia[J]. J Rheumatol, 2011, 38(6):1113-1122.
[4] Wolfe F, Häuser W, Hassett AL, et al. The development of fibromyalgia: Ⅰ examination of rates and predictors in patients with rheumatoid arthritis (RA)[J]. Pain, 2011, 152(2):291-299.
doi: 10.1016/j.pain.2010.09.027
[5] Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: A population-based study in olmsted county, minnesota, utilizing the rochester epidemiology project[J]. Arthritis Care Res (Hoboken), 2013, 65(5):786-792.
doi: 10.1002/acr.21896 pmid: 23203795
[6] Joharatnam N, McWilliams DF, Wilson D, et al. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis[J]. Arthritis Res Ther, 2015, 17(1):11.
doi: 10.1186/s13075-015-0525-5
[7] Kılıçarslan A, Yurdakul FG, Bodur H. Diagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity[J]. Turk J Phys Med Rehabil, 2018, 64(2):133-139.
[8] Abbasi L, Haidri FR. Fibromyalgia complicating disease management in rheumatoid arthritis[J]. J Coll Physicians Surg Pak, 2014, 24(6):424-427.
[9] Pollard LC, Kingsley GH, Choy EH, et al. Fibromyalgic rheu-matoid arthritis and disease assessment[J]. Rheumatology (Oxford), 2010, 49(5):924-928.
doi: 10.1093/rheumatology/kep458 pmid: 20100795
[10] Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia[J]. Arthritis Rheum, 1990, 33(2):160-172.
doi: 10.1002/(ISSN)1529-0131
[11] Mu R, Li C, Zhu JX, et al. National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China[J]. Int J Rheum Dis, 2013, 16(3):258-263.
doi: 10.1111/1756-185X.12055
[12] Queiroz LP. Worldwide epidemiology of fibromyalgia[J]. Curr Pain Headache Rep, 2013, 17(8):356.
doi: 10.1007/s11916-013-0356-5
[13] Wolfe F, Hauser W. Fihromyalgia diagnosis and diagnostic criteria[J]. Ann Med, 2011, 43(7):495-502.
doi: 10.3109/07853890.2011.595734
[14] Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic critera[J]. Semin Arthritis Rheum, 2016, 46(3):319-329.
doi: 10.1016/j.semarthrit.2016.08.012
[15] Kim H, Cui J, Frits M, et al. Fibromyalgia and the prediction of two-year changes in functional status in rheumatoid arthritis patients[J]. Arthritis Care Res (Hoboken), 2017, 69(12):1871-1877.
doi: 10.1002/acr.v69.12
[16] Gist AC, Guymer EK, Eades LE, et al. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia[J]. Int J Rheum Dis, 2018, 21(3):639-646.
doi: 10.1111/apl.2018.21.issue-3
[17] Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia[J]. Ann Rheum Dis, 2017, 76(2):318-328.
doi: 10.1136/annrheumdis-2016-209724 pmid: 27377815
[18] 焦娟, 贾园, 吴庆军, 等. 解读2017年欧洲抗风湿病联盟纤维肌痛治疗管理建议[J]. 中华风湿病学杂志, 2018, 22(1):68-69.
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Lingfu ZHANG, Ming CHEN, Xiaoyu ZHAO, Gang WANG, Long CUI, Xiaofeng LING, Lixin WANG, Zhi XU, Limei GUO, Chunsheng HOU. Gross classification of gallbladder cancer with primary lesion limited to the gallbladder wall and its correlation with prognosis and precancerous lesions [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 184-189.
[3] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[4] Yan DING, Lifang WANG, Chaoran LI, Zhemin LU, Lianjie SHI. Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1203-1207.
[5] Ju YANG, Jing XU, Juhua DAI, Lianjie SHI. Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 911-918.
[6] Lianghua FENG, Lirong HONG, Yujia CHEN, Xueming CAI. Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 919-925.
[7] Fengyi HU, Qingyang MENG, Nayun CHEN, Jianing WANG, Zhenlong LIU, Yong MA, Yuping YANG, Xi GONG, Cheng WANG, Ping LIU, Weili SHI. Clinical efficacy of arthroscopic medial patellofemoral complex reconstruction for recurrent patellar dislocation with high-grade trochlear dysplasia [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 947-955.
[8] Yaqun FU, Jiawei ZHANG, Bing HAN, Quan WANG, Zheng ZHU, Zhijie NIE, Yiyang TAN, Qing LIU, Xiaoguang LI, Jing GUO, Rongmeng JIANG, Li YANG. Healthcare institution resilience and the influencing factors during infectious disease outbreaks [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 529-536.
[9] Jianjun SUN, Qianquan MA, Xiaoliang YIN, Chenlong YANG, Jia ZHANG, Suhua CHEN, Chao WU, Jingcheng XIE, Yunfeng HAN, Guozhong LIN, Yu SI, Jun YANG, Haibo WU, Qiang ZHAO. Significance of precise classification of sacral meningeal cysts by multiple dimensions radiographic reconstruction MRI in guiding operative strategy and rehabilitation [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 303-308.
[10] Meijuan LONG, Yidan WANG, Shiya WU, Zihao LI, Yanting LI, Yang LI, Juan JIAO. Effects of overweight and obesity on symptoms, overall condition and quality of life in patients with fibromyalgia syndrome [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1001-1008.
[11] Peiwen JIA, Ying YANG, Yaowei ZOU, Zhiming OUYANG, Jianzi LIN, Jianda MA, Kuimin YANG, Lie DAI. Clinical characteristics of overlapping syndromes of low muscle mass in patients with rheumatoid arthritis and their impact on physical function [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1009-1016.
[12] Doudou MA, Zhemin LU, Qian GUO, Sha ZHU, Jin GU, Yan DING, Lianjie SHI. Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1110-1114.
[13] Rui YAN, Dan KE, Yan ZHANG, Li LI, Huanran SU, Wei CHEN, Mingxia SUN, Xiaomin LIU, Liang LUO. Diagnostic significance of serum chemokine CXCL-10 and Krebs von den lungen-6 level in patients with rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 956-962.
[14] Liang ZHAO, Chenglong SHI, Ke MA, Jing ZHAO, Xiao WANG, Xiaoyan XING, Wanxing MO, Yirui LIAN, Chao GAO, Yuhui LI. Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 972-979.
[15] Yijun HAN, Xiaoli CHEN, Changhong LI, Jinxia ZHAO. Application status of methotrexate in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 994-1000.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!